Navigation Links


Opal Kelly Announces ZEM5310 with Altera Cyclone V E and FrontPanel SDK

1/18/2017
Portland, OR (PRWEB) January 18, 2017 Opal Kelly, a leading producer of powerful FPGA modules that provide essential device-to-computer interconnect using USB or PCI Express, announced the ZEM5310 USB 3.0 FPGA Module, combining a SuperSpeed USB 3.0 interface and an Altera Cyclone V E FPGA int... [Comments]

In situ Hybridization Market Worth 739.9 Million USD by 2021

1/18/2017
PUNE, India , January 18, 2017 According to a new market research report "In situ Hybridization Market by Technique (FISH, CISH), Application (Cancer Diagnosis, Neuroscience, Cytology, Infectious Disease), & End User (Molecular Diagnostic Laboratories, Academic and Research Institutions) - Global Forecast to 2021" published by MarketsandMarkets, the market is expected to... [Comments]

Boston Biomedical to Highlight Data for Cancer Stemness Inhibitor Napabucasin in Patients with Colorectal Cancer at 2017 ASCO GI

1/18/2017
CAMBRIDGE, Mass. , Jan. 18, 2017   Boston Biomedical , an industry leader in the development of novel compounds designed to target cancer stemness pathways, will feature data from two clinical studies for its lead investigational compound, napabucasin, at the 2017 ASCO Gastrointestinal Cancers Symposium, held from January 19-21, in San Francisco . Napabucasin is an o... [Comments]

Applied BioMath, LLC to present at Boston Area Group for Informatics and Modeling Meeting

1/18/2017
LINCOLN, Mass. , Jan. 18, 2017 Applied BioMath ( www.appliedbiomath.com ), the industry-leader in applying mechanistic modeling to drug research and development, today announced that Dr. John Burke , PhD, Co-Founder, President, and CEO of Applied BioMath, will present at the next Boston Area Group for Informatics and Modeling (BAGIM) Meeting on Thursday January 19, 2017 at th... [Comments]

Parent Project Muscular Dystrophy Awards NJIT and Talem Technologies a $600,000 Grant to Continue Exploration of an Upper Extremity Exoskeleton in Duchenne Muscular Dystrophy

1/18/2017
HACKENSACK, N.J. , Jan. 18, 2017   Parent Project Muscular Dystrophy (PPMD) , a nonprofit organization leading the fight to end Duchenne muscular dystrophy (Duchenne) , today announced a $600,000 grant to be awarded to the New Jersey Institute of Technology (NJIT) and Talem Technologies (Talem) as part of the organization's ongoing exploration of robotic techn... [Comments]

Slone Partners Sponsors the SCOPE Summit for Clinical Ops Executives 2017

1/18/2017
(PRWEB) January 18, 2017 Executive search firm Slone Partners proudly supports the SCOPE Summit for Clinical Ops Executives 2017 in its continued commitment to the advancement of the clinical trials segment. Hosted in Miami, this conference brings together renowned decision makers to discuss... [Comments]

SpineFrontier Announces Increasing Adoption of Its A-CIFT™ Solofuse-P Standalone Cervical Interbody by Younger Surgeons Like Dr. Dante Leven

1/18/2017
Malden, MA (PRWEB) January 18, 2017 Total Orthopedics and Sports Medicine ( http://www.totalorthosportsmed.com ) announced today that Dr. Dante Leven successfully implanted SpineFrontier’s A-CIFT™ Solofuse-P™. The operation took place on Wednesday, January 11, 2017 at Long Island Jewish, Vall... [Comments]

Whitehouse Labs Increases Focus and Expertise In Extractables & Leachables

1/18/2017
Whitehouse, NJ (PRWEB) January 18, 2017 Whitehouse Labs has furthered its efforts towards gaining access to more and more E&L expertise. Within Albany Molecular Research, Inc. (AMRI), the scientific staff dedicated to Extractables / Leachables & Impurities has more than doubled in the... [Comments]

RoosterBio Inc. Unites with Manufacturing Innovation Institutes, Joining Manufacturing USA Network

1/18/2017
Frederick, Maryland (PRWEB) January 18, 2017 Announced in December 2016, RoosterBio is now part of two new federally funded bio-focused Manufacturing Innovation Institutes (MII). U.S. Secretary of Commerce Penny Pritzker has announced the award of a new National Institute for Innovation in Ma... [Comments]

MYOLYN Submits Application for FDA Clearance of its MyoCycle Device

1/18/2017
Gainesville, FL (PRWEB) January 18, 2017 MYOLYN, which creates medical technology for people with muscle weakness and paralysis, today announced that it has submitted a 510(k) to the FDA, requesting clearance of the MyoCycle Home and the MyoCycle Pro – stationary bikes that utilize MYOLYN’s p... [Comments]

[next]
(Date:1/3/2017)... 2017 Onitor, provider of digital health technology ... an innovative biometric data-driven program designed to aid weight ... the 2017 Consumer Electronics Show (CES) in ... U.S., the World Health Organization (WHO), have identified lifestyle ... who are overweight or obese. WHO also states that ...
(Date:12/20/2016)... and GENEVA, Dec, 20, 2016   Valencell ... sensor technology, and STMicroelectronics (NYSE: STM), a ... of electronics applications, announced today the launch of ... for biometric wearables that includes ST,s compact ... Valencell,s Benchmark™ biometric sensor system. Together, SensorTile ...
(Date:12/16/2016)... The global wearable medical device market, in terms of value, is ... billion in 2016, at a CAGR of 18.0% during the forecast ... Growth ... devices, launch of a growing number of smartphone-based healthcare apps compatible ... and increasing focus on physical fitness. Furthermore, growing ...
Breaking Biology News(10 mins):
... to Asparagine synthetase ( Abpromise ... Antigen: ... in the C-terminus of Human ... Entrez GeneID: 440 ...
Rabbit Anti-melatonin (different linkage) Polyclonal Antibody...
Phospho-PERK (Thr980) Antibody...
MDMA Mouse Monoclonal Antibody (Clone 3G8)...
Biology Products:
(Date:1/17/2017)... Point, IA (PRWEB) , ... January 17, 2017 ... ... from China for Balance™ GT soybeans. The new Balance™ GT Soybean Performance System ... to glyphosate and isoxaflutole, the active ingredient in the new Balance® Bean herbicide. ...
(Date:1/17/2017)... -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today ... earnings conference call will be broadcast live over the ... Eastern Time.  A news release detailing the quarterly and ... Eastern Time the morning of the conference call. ... Zimmer Biomet,s Investor Relations website at http://investor.zimmerbiomet.com . ...
(Date:1/17/2017)... , Jan. 17, 2017  Only nine percent ... patients over profits, while only 16 percent believe health ... released today. Meanwhile, 36 percent of U.S. adults believe ... patients over profits, compared to hospitals (23%). ... maelstrom," said Wendy Salomon , vice president of ...
(Date:1/17/2017)... Boston, MA (PRWEB) , ... January 17, 2017 ... ... of the completely re-engineered Drug Safety Technology Consortium™ (SafeTEC™), $3 million in investment ... be validating these new tools and assays, and their applicability in drug safety ...
Breaking Biology Technology: